$2.49T
Total marketcap
$66.74B
Total volume
BTC 50.20%     ETH 16.11%
Dominance

Real Brands RLBD Stock

0.0027 USD {{ price }} 0.000000% {{change_pct}}%
Exchange
Other OTC
Market Cap
7.26M USD
LOW - HIGH [24H]
0.0027 - 0.0027 USD
VOLUME [24H]
403 USD
{{ volume }}
P/E Ratio
0
Earnings per share
0 USD

Real Brands Price Chart

Real Brands RLBD Financial and Trading Overview

Real Brands stock price 0.0027 USD
Previous Close 0.0085 USD
Open 0.0078 USD
Bid 0 USD x 0
Ask 0 USD x 0
Day's Range 0.0085 - 0.0085 USD
52 Week Range 0.0045 - 0.02 USD
Volume 56.75K USD
Avg. Volume 100.7K USD
Market Cap 22.87M USD
Beta (5Y Monthly) -0.353311
PE Ratio (TTM) N/A
EPS (TTM) 0 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

RLBD Valuation Measures

Enterprise Value 23.65M USD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 862.15704
Price/Book (mrq) N/A
Enterprise Value/Revenue 891.554
Enterprise Value/EBITDA -18.309

Trading Information

Real Brands Stock Price History

Beta (5Y Monthly) -0.353311
52-Week Change -59.52%
S&P500 52-Week Change 20.43%
52 Week High 0.02 USD
52 Week Low 0.0045 USD
50-Day Moving Average 0.0075408 USD
200-Day Moving Average 0.00898185 USD

RLBD Share Statistics

Avg. Volume (3 month) 100.7K USD
Avg. Daily Volume (10-Days) 140.82K USD
Shares Outstanding 2.69B
Float 928.89M
Short Ratio N/A
% Held by Insiders 65.68%
% Held by Institutions 0%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 1:150

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) -5180.28%
Gross Margin 31.57%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -72.39%
Return on Equity (ttm) N/A

Income Statement

Revenue (ttm) 26.53K USD
Revenue Per Share (ttm) 0 USD
Quarterly Revenue Growth (yoy) 224.59%
Gross Profit (ttm) N/A
EBITDA -1291703 USD
Net Income Avi to Common (ttm) -1392416 USD
Diluted EPS (ttm) 0
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 3.55K USD
Total Cash Per Share (mrq) 0 USD
Total Debt (mrq) 783.37K USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 0.002
Book Value Per Share (mrq) 0

Cash Flow Statement

Operating Cash Flow (ttm) -416671 USD
Levered Free Cash Flow (ttm) 90.19K USD

Profile of Real Brands

Country United States
State RI
City North Providence
Address 12 Humbert Street
ZIP 02991
Phone 617 803 0004
Website https://www.realbrandsusa.com
Industry Drug Manufacturers-Specialty & Generic
Sector(s) Healthcare
Full Time Employees 3

Real Brands, Inc. engages in the extraction of hemp cannabinol (CBD) oil/isolate, wholesale of CBD oils and isolate, and production and sale of hemp-derived CBD products. It offers topical creams and gels, cosmetics, tinctures, oils, capsules, vape cartridges, oral sprays, lotions, and other products. The company was founded in 2011 and is headquartered in North Providence, Rhode Island.

Q&A For Real Brands Stock

What is a current RLBD stock price?

Real Brands RLBD stock price today per share is 0.0027 USD.

How to purchase Real Brands stock?

You can buy RLBD shares on the Other OTC exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Real Brands?

The stock symbol or ticker of Real Brands is RLBD.

Which industry does the Real Brands company belong to?

The Real Brands industry is Drug Manufacturers-Specialty & Generic.

How many shares does Real Brands have in circulation?

The max supply of Real Brands shares is 2.69B.

What is Real Brands Price to Earnings Ratio (PE Ratio)?

Real Brands PE Ratio is now.

What was Real Brands earnings per share over the trailing 12 months (TTM)?

Real Brands EPS is 0 USD over the trailing 12 months.

Which sector does the Real Brands company belong to?

The Real Brands sector is Healthcare.